tiprankstipranks
Corcept Therapeutics (CORT)
NASDAQ:CORT
US Market
CORT
Corcept Therapeutics
RESEARCH TOOLSreports
Want to see CORT full AI Analyst Report?

Corcept Therapeutics (CORT) Ratios

1,309 Followers

Corcept Therapeutics Ratios

CORT's free cash flow for Q1 2026 was $0.98. For the 2026 fiscal year, CORT's free cash flow was decreased by $ and operating cash flow was $-0.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.86 2.92 3.35 4.39 6.89
Quick Ratio
 2.77 2.85 3.26 4.31 6.80
Cash Ratio
 0.73 0.73 0.91 1.30 0.91
Solvency Ratio
 0.28 0.54 0.88 0.93 1.26
Operating Cash Flow Ratio
 0.81 0.85 1.41 1.22 1.66
Short-Term Operating Cash Flow Coverage
 73.81 130.99 238.92 841.32 105.27
Net Current Asset Value
$ 249.14M$ 296.62M$ 310.64M$ 343.82M$ 417.67M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.02 <0.01 0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.01 <0.01 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.28 1.29 1.24 1.23 1.16
Debt Service Coverage Ratio
 17.81 73.69 142.34 595.41 86.72
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.09 0.06 0.07 <0.01 0.01
Net Debt to EBITDA
 14.59 -2.45 -0.87 -1.25 -0.57
Profitability Margins
Gross Profit Margin
98.25%98.30%98.39%98.66%98.66%
EBIT Margin
-1.07%5.88%20.29%22.24%28.03%
EBITDA Margin
-0.88%6.13%20.49%22.46%28.34%
Operating Profit Margin
-1.07%5.88%20.29%22.24%28.03%
Pretax Profit Margin
1.58%8.73%23.92%25.82%28.91%
Net Profit Margin
6.23%13.09%20.70%22.00%25.24%
Continuous Operations Profit Margin
6.23%13.09%20.92%22.00%25.24%
Net Income Per EBT
394.91%149.94%86.53%85.21%87.29%
EBT Per EBIT
-147.57%148.36%117.92%116.10%103.16%
Return on Assets (ROA)
5.88%11.91%16.62%17.08%17.38%
Return on Equity (ROE)
7.50%15.38%20.56%20.95%20.21%
Return on Capital Employed (ROCE)
-1.23%6.68%19.57%20.75%22.04%
Return on Invested Capital (ROIC)
-1.23%6.67%17.09%17.68%19.20%
Return on Tangible Assets
5.88%11.91%16.62%17.08%17.38%
Earnings Yield
0.66%2.76%2.69%3.16%4.68%
Efficiency Ratios
Receivables Turnover
 19.68 12.74 11.62 8.49 8.58
Payables Turnover
 0.40 0.32 0.71 0.37 0.45
Inventory Turnover
 1.04 1.01 0.88 0.84 0.88
Fixed Asset Turnover
 74.19 117.63 84.24 1.53K 226.27
Asset Turnover
 0.94 0.91 0.80 0.78 0.69
Working Capital Turnover Ratio
 2.58 2.34 1.97 1.24 1.24
Cash Conversion Cycle
 -535.21 -746.96 -68.02 -501.38 -355.72
Days of Sales Outstanding
 18.54 28.66 31.40 43.00 42.56
Days of Inventory Outstanding
 349.62 361.93 416.32 435.34 413.46
Days of Payables Outstanding
 903.37 1.14K 515.74 979.72 811.74
Operating Cycle
 368.16 390.59 447.72 478.34 456.02
Cash Flow Ratios
Operating Cash Flow Per Share
 1.15 1.37 1.92 1.23 1.13
Free Cash Flow Per Share
 1.15 1.37 1.90 1.23 1.12
CapEx Per Share
 <0.01 <0.01 0.02 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 0.99 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 389.92 672.97 91.19 913.95 291.34
Capital Expenditure Coverage Ratio
 389.92 672.97 91.19 913.95 291.34
Operating Cash Flow Coverage Ratio
 12.46 23.25 28.56 841.32 105.27
Operating Cash Flow to Sales Ratio
 0.16 0.19 0.29 0.26 0.30
Free Cash Flow Yield
1.61%3.92%3.77%3.77%5.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 158.32 36.27 37.23 31.69 21.39
Price-to-Sales (P/S) Ratio
 10.14 4.75 7.71 6.97 5.40
Price-to-Book (P/B) Ratio
 11.89 5.58 7.65 6.64 4.32
Price-to-Free Cash Flow (P/FCF) Ratio
 65.08 25.49 26.55 26.51 18.09
Price-to-Operating Cash Flow Ratio
 63.15 25.45 26.26 26.48 18.03
Price-to-Earnings Growth (PEG) Ratio
 -2.45 -1.22 1.15 4.30 -10.37
Price-to-Fair Value
 11.89 5.58 7.65 6.64 4.32
Enterprise Value Multiple
 -1.13K 74.97 36.74 29.80 18.47
Enterprise Value
 7.36B 3.50B 5.08B 3.23B 2.10B
EV to EBITDA
 -1.08K 74.97 36.74 29.80 18.47
EV to Sales
 9.57 4.60 7.53 6.69 5.23
EV to Free Cash Flow
 61.45 24.69 25.94 25.44 17.54
EV to Operating Cash Flow
 61.29 24.65 25.65 25.41 17.48
Tangible Book Value Per Share
 6.11 6.24 6.58 4.89 4.70
Shareholders’ Equity Per Share
 6.11 6.24 6.58 4.89 4.70
Tax and Other Ratios
Effective Tax Rate
 -2.95 -0.50 0.13 0.15 0.13
Revenue Per Share
 7.36 7.33 6.54 4.66 3.76
Net Income Per Share
 0.46 0.96 1.35 1.02 0.95
Tax Burden
 3.95 1.50 0.87 0.85 0.87
Interest Burden
 -1.48 1.48 1.18 1.16 1.03
Research & Development to Revenue
 0.34 0.33 0.37 0.38 0.33
SG&A to Revenue
 0.65 0.59 0.42 0.00 0.00
Stock-Based Compensation to Revenue
 -0.03 0.11 0.09 0.10 0.11
Income Quality
 0.99 1.45 1.40 1.20 1.19
Currency in USD